DSpace
 

Rubicon Research Repository >
Rubicon Foundation Archive >
Undersea and Hyperbaric Medicine Journal >

Please use this identifier to cite or link to this item: http://archive.rubicon-foundation.org/8038

Title: De novo cataract development following a standard course of hyperbaric oxygen therapy.
Authors: Gesell, LB
Trott, A
Keywords: hyperbaric oxygenation
cataract development
ophthalmic
eye
myopia
case report
human
Issue Date: 2007
Publisher: Undersea and Hyperbaric Medical Society
Citation: Undersea Hyperb Med. 2007 Nov-Dec;34(6):389-92.
Abstract: A 49 y/o female under went 48 hyperbaric oxygen (HBO2) treatments at 2.5 ATA (atmospheres absolute) (253 kPa) for 90 minutes for chronic refractory osteomyelitis of the sacrum and recurrent failure of a sacral myocutaneous flap. Prior to HBO2 therapy, formal ophthalmic exams revealed myopia but no evidence of cataract formation. Eight weeks following the completion of HBO2 therapy, on repeat ophthalmic exam, the patient was discovered to have worsening myopia. Changes of the crystalline lens, consistent with nuclear cataract development, were identified in each eye. Other common causes of cataract formation including diabetes, corticosteroid use, and excessive exposure to ultraviolet light, were excluded. While transient visual changes are known to occur during HBO2 therapy, cataract formation has only rarely been reported and only after prolonged courses of treatment (150 or more treatments). This case identifies the need to further investigate the ocular effects of HBO2 therapy, especially with regard to cataract development and progression.
Description: Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc.
URI: http://archive.rubicon-foundation.org/8038
ISBN: 1066-2936
Appears in Collections:Undersea and Hyperbaric Medicine Journal

Files in This Item:

File Description SizeFormat
18251434.pdf199KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

  Copyright © 2004-2006 Rubicon Foundation, Inc. - Feedback